Analyst says Novo rebrand signals strategy shift, not just marketing
A Seeking Alpha commentary argues the drugmaker's name change reflects deeper corporate repositioning beyond public relations.
TR
By Tom Reyes · Markets Editor
Sep 16 15:33 ETSource: Seeking Alpha
The wire
- 01A Seeking Alpha piece contends Novo's corporate rebrand goes beyond PR posturing.
- 02Framing matters as investors assess whether Novo is restructuring its obesity strategy.
- 03The thesis is opinion; company confirmation of strategic changes is pending.
From the source
Read at news.google.comNovo Nordisk: Why This Corporate Rebrand Is More Than Simply PR Posturing (NYSE:NVO)